Diagnostic Accuracy of Bisphosphonate Scintigraphy in Glu54GlnATTR Cardiomyopathy
<b>Background:</b> Bisphosphonate scintigraphy (BS) is a recognized tool for diagnosing amyloid transthyretin cardiomyopathy (ATTR-CA). However, its sensitivity for rare transthyretin (TTR) variants, like Glu54Gln, remains underexplored. <b>Methods</b>: This was a retrospective descriptive study including all known patients with the Glu54Gln variant diagnosed between 2017 and 2023 in Romania, aiming to evaluate the diagnostic performance of BS in Glu54Gln ATTR-CA. <b>Results</b>: All symptomatic patients (<i>n</i> = 22) with histologically confirmed ATTR-CA had positive BS results (100% sensitivity). No false negatives were observed in asymptomatic carriers (<i>n</i> = 4). The Perugini visual score correlated with disease severity, with grade 3 scores associated with advanced cardiac involvement. We proposed a new parameter, heart-to-liver-uptake (H/L) ratio, which proved a strong positive correlation with both the heart-to-contralateral-uptake (H/CL) ratio (R<sup>2</sup> = 0.768, <i>p</i> < 0.001) and interventricular septum thickness (R<sup>2</sup> = 0.584, <i>p</i> < 0.001) and a weak correlation with the global longitudinal strain (R<sup>2</sup> = 0.212, <i>p</i> = 0.023). <b>Conclusions</b>: BS demonstrates high diagnostic accuracy for Glu54GlnATTR-CA, underscoring its utility in early diagnosis and clinical management. The H/L ratio presents a novel approach to semiquantitative analysis of bisphosphonate uptake in cardiac amyloidosis, potentially addressing key limitations of the traditional H/CL ratio.
Authors
- Sorina Bădeliță (ORCID: https://orcid.org/0000-0002-1507-2547)
- Camelia Dobrea (ORCID: https://orcid.org/0000-0003-0607-8573)
- Irena Grierosu (ORCID: https://orcid.org/0000-0002-4881-5407)
- Gabriela Neculae (ORCID: https://orcid.org/0000-0003-1764-3291)
- Cipriana Ștefănescu (ORCID: https://orcid.org/0000-0001-9697-750X)
- Sebastian Onciul (ORCID: https://orcid.org/0000-0002-1729-0126)
- Ana-Maria Stătescu
- Robert Adam (ORCID: https://orcid.org/0000-0002-5018-1482)
- Ruxandra Jurcuţ (ORCID: https://orcid.org/0000-0002-3438-2612)
- Claudiu Stan (ORCID: https://orcid.org/0000-0003-4430-1588)
- D. Stanescu
- Daniel Coriu (ORCID: https://orcid.org/0000-0002-7251-6079)
- Răzvan Alexandru Capşa
- Mirela Drăghici (ORCID: https://orcid.org/0000-0001-6738-9186)
- Andreea Jercan (ORCID: https://orcid.org/0000-0003-3046-1126)
- Mihai Guțu (ORCID: https://orcid.org/0000-0002-0763-0449)
- Alessia Argirò (ORCID: https://orcid.org/0000-0002-6394-9948)
- Francesco Cappelli (ORCID: https://orcid.org/0000-0002-1622-0732)
- Cristina Chirion
- Teodor-Marian Ionescu
Institutions
- Ştefan cel Mare University of Suceava (RO)
- Carol Davila University of Medicine and Pharmacy (RO)
- Clinical Emergency Hospital Bucharest (RO)
- Grigore T. Popa University of Medicine and Pharmacy (RO)
- Institutul de Urgenţă pentru Boli Cardiovasculare "Prof.Dr. C.C. Iliescu" (RO)
- Azienda Ospedaliero-Universitaria Careggi (IT)
- Spitalul Clinic Judeţean de Urgenţe "Sf. Spiridon" Iaşi (RO)
- Institutul Clinic Fundeni (RO)
- University of Florence (IT)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2025-05-26
- DOI
- https://doi.org/10.3390/jcm14113734
- Primary Topic
- Amyloidosis: Diagnosis, Treatment, Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00